Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,201,492
-$47,048 QoQ
Shares Held
20,852
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,067
of 2,514 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRIVATE MANAGEMENT GROUP INC holds $81,148,521 across 8 Drug Manufacturers - General names. BMY ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OGN |
Organon & Co.
|
3,742,161 | $50,668,859 | |
| 2 | JNJ |
Johnson & Johnson
|
58,327 | $14,813,308 | |
| 3 | ABBV |
AbbVie Inc.
|
33,546 | $8,441,515 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,282 | $2,863,237 | |
| 5 | PFE |
Pfizer Inc
|
81,843 | $1,970,779 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
20,852 | $1,201,492 | |
| 7 | LLY |
ELI LILLY & Co
|
552 | $662,085 | |
| 8 | AMGN |
Amgen Inc
|
1,456 | $527,246 |
All Filings in BMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,201,492 | 20,852 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,248,540 | 20,586 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,108,574 | 20,552 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $926,895 | 20,552 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $951,352 | 20,552 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||